View Document Preview and Link Document Date: 2015-03-04 23:43:08 Open Document File Size: 48,54 KB Share Result on Facebook
Company C1 / / / Event FDA Phase / / / IndustryTerm proposed management algorithms / treatment of the underlying disease / clinical management algorithms / draft protocol / on-line survey / medicinal products / / MedicalCondition CONDITION (DISEASE) Hereditary / lymphoma / disease / autosomal dominant disorder / HAE / C1-INH deficiency / urticaria / angioedema / angioedema attacks / acute angioedema attacks / infections / / MedicalTreatment oral therapy / / Organization Australasian Society of Clinical Immunology and Allergy / Current C1-INH administration / Department of Health / Medical Services Advisory Committee / / / Position Governor / General practitioner Specialist Researcher / / Product INH / danazol / C1-INH / Application / / Technology draft protocol / proposed management algorithms / ASCIA management algorithm / clinical management algorithms / / SocialTag 
Application 1394 – C1 Esterase Inhibitor (C1-INH) The Department of Health is seeking your feedback on the draft protocol for Application 1394 – C1 Esterase Inhibitor (C1-INH). Please note, this protocol is yet to